PEDF (encoded by SERPINF1), a known adipokine, has been implicated in the pathophysiology of type 2 diabetes due to its strong association with cardiometabolic risk factors such as obesity-associated inflammation and insulin resistance (73, 74). Here, SERPINF1 is linked to obesity due to melanocortin 4 receptor deficiency.